Patent Assignment
Reel/Frame 022790/0964
Assignment of Assignor's Interest
Recorded: 2009-06-08
Pages: 5
Assignor
KLINGEMANN, HANS
Executed: 2009-06-04
Assignee
ZELLERX CORPORATION
15502 CHURCHILL DOWNS, BOX 3861, RANCHO SANTA FE, CALIFORNIA, 92067
Covered Properties
(5)
Natural killer cell lines and methods of use
Interleukin-Secreting Natural Killer Cell Lines and Methods of Use
Cancer cell receptor-expressing natural killer cell lines and methods of use
Application:
10/456,620 →
Publication:
US 2004/0022773
Thymidine kinase expressing natural killer cell lines and methods of use
Application:
10/456,779 →
Publication:
US 2004/0018182
Methods of treating tumors using natural killer cell lines
Application:
10/701,359 →
Publication:
US 2006/0110360
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Oct 6, 2009
From: ZELLERX CORPORATION
To: MOSKOVITS, DAVID; SCHLESINGER, MICHAEL; ANDREW SCHLESINGER DEFINED BENEFIT PLAN; SPREI, ELI INZLICHT
Reel/Frame 023332/0107 →
Change of Name
Jun 2, 2011
From: ZELLERX CORPORATION
To: CONKWEST, INC.
Reel/Frame 026382/0184 →
Change of Name
Mar 11, 2016
From: CONKWEST, INC.
To: NANTKWEST, INC.
Reel/Frame 038071/0681 →
Change of Name
Sep 23, 2018
From: CONKWEST, INC.
To: NANTKWEST, INC.
Reel/Frame 047129/0204 →
Release of Security Interest
Jul 23, 2021
From: CONKWEST, INC.
To: WEISS, ANNIE; DAYAN, RAYMOND; BUXBAUM, GARY; LOWEY, ELIOT
Reel/Frame 056970/0001 →
Change of Name
Aug 2, 2021
From: NANTKWEST, INC.
To: IMMUNITYBIO, INC.
Reel/Frame 057059/0802 →
Security Interest
Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →